MALAT1 and hepatocellular carcinoma: Therefore, our data indicated that GA suppressed tumorigenesis by modulating lncRNA MALAT1-Wnt/β-catenin signaling axis in HCC, suggesting that it may be a promising drug candidate for HCC patients.